查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1498775

呼吸道合胞病毒藥物市場，按類型、應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Respiratory Syncytial Virus Drugs Market, By Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年呼吸道合胞病毒藥物市場規模為58.902億美元，2024年至2032年複合年成長率為12.90%。

呼吸道合胞病毒藥物市場-市場動態

人們對 RSV 感染和診斷的認知不斷提高預計將推動市場需求

由於對 RSV 知識的增加和診斷方法的改進，對 RSV 藥物和預防性治療的需求增加，這導致感染診斷更加頻繁和早期。對於小孩和老年人來說，呼吸道疾病大多是由 RSV 引起的。 RSV 感染的高盛行率和復發性推動了對有效治療和預防策略的需求。重要的推動因素包括新型抗病毒藥物、單株抗體和疫苗的開發和許可。由於有效治療方法的引入和治療替代方案的創新，預計該市場將會成長。

人口老化推動了對有效 RSV 藥物的需求，他們更容易受到嚴重 RSV 感染。預計隨著世界人口老化，RSV 發病率將在這群人中攀升，從而推動市場需求。由於生物技術和製藥的發展，新療法和疫苗的開發變得越來越容易。這些技術進步提高了 RSV 藥物的可用性和療效，從而推動了市場擴張。新藥和疫苗的監管批准為該行業帶來了巨大推動力。 RSV 藥物的快速通道指定和有利的監管條件可以促進市場的成長。

呼吸道合胞病毒藥物市場-關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 12.90% 左右的複合年成長率成長

根據類型細分，由於美國 FDA 法規的支持，預計已批准的藥物細分市場將在 2023 年顯示最大的市場佔有率。

根據應用細分，由於臨床試驗和治療中對病毒藥物的高需求，臨床診斷領域是 2023 年的領先應用。

根據最終用戶細分，由於呼吸系統疾病治療的需求很高，醫院細分市場將在 2023 年成為領先的最終用戶。

按地區分類，由於擁有先進的醫療基礎設施，北美將成為 2023 年的主要收入來源。

呼吸道合胞病毒藥物市場-細分分析：

全球呼吸道合胞病毒藥物市場根據類型、應用、最終用戶和地區進行細分。

市場依類型分為兩類：核准藥物和適應證外藥物。已批准的藥物領域主導市場。技術創新以及 FDA 的支持性法規正在促進該細分市場的成長。

根據應用市場分為三類：臨床診斷、實驗室和其他。實體門市細分市場佔據主導地位。合胞病毒感染的日益普及是市場成長的迫切需求。

市場根據最終用戶分為三類：醫院、診所和其他。醫院領域在市場中佔據主導地位，預計在預測期內將保持其高度主導地位。對醫療保健和先進基礎設施的大量投資正在加速市場的成長。

呼吸道合胞病毒藥物市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。北美正在主導全球市場。由於其大量的研發支出、先進的醫療基礎設施和高額的醫療保健支出，該地區佔有較大的市場佔有率，北美是 RSV 藥物的最大市場之一。

呼吸道合胞病毒藥物市場-競爭格局：

呼吸道合胞病毒藥物市場競爭中等。市場上的知名企業專注於製藥公司、學術機構和醫療保健提供者之間的合作，這可能會加速 RSV 藥物的創造和傳播，從而擴大市場。一些主要公司包括阿斯特捷利康 (AstraZeneca)、強生 (Johnson & Johnson)、賽諾菲 (Sanofi)、默克 (Merck & Co.) 以及 Moderna 等新公司。較小的公司正在尋求提供創新的解決方案並獲得美國食品和藥物管理局的批准。

最近的發展：

2024 年 2 月，葛蘭素史克公司 (GSK plc) 獲得美國 FDA 批准，擴大其呼吸道合胞病毒疫苗接種範圍，涵蓋 50 歲以上人口。

2023 年 5 月，輝瑞公司推出了經美國 FDA 批准的二價 RSV 疫苗，用於預防呼吸道疾病。

目錄

第1章：呼吸道合胞病毒藥物市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的呼吸道合胞病毒藥物市場片段
    • 呼吸道合胞病毒藥物市場片段（依應用）
    • 最終用戶的呼吸道合胞病毒藥物市場片段
    • 按國家/地區分類的呼吸道合胞病毒藥物市場片段
    • 按地區分類的呼吸道合胞病毒藥物市場片段
  • 競爭洞察

第 3 章：呼吸道合胞病毒藥物主要市場趨勢

  • 呼吸道合胞病毒藥物市場促進因素
    • 市場促進因素的影響分析
  • 呼吸道合胞病毒藥物市場限制
    • 市場限制影響分析
  • 呼吸道合胞病毒藥物市場機會
  • 呼吸道合胞病毒藥物市場未來趨勢

第 4 章：呼吸道合胞病毒藥物產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：呼吸道合胞病毒藥物市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：呼吸道合胞病毒藥物市場格局

  • 2023年呼吸道合胞病毒藥物市佔分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：呼吸道合胞病毒藥物市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 批准的藥物
    • 標籤外藥物

第 8 章：呼吸道合胞病毒藥物市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 臨床診斷
    • 實驗室
    • 其他

第 9 章：呼吸道合胞病毒藥物市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 其他

第 10 章：呼吸道合胞病毒藥物市場 - 依地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美呼吸道合胞病毒藥物主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲呼吸道合胞病毒藥物主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區呼吸道合胞病毒藥物主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲呼吸道合胞病毒藥物主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲呼吸道合胞病毒藥物主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析-呼吸道合胞病毒藥物產業

  • 競爭儀表板
  • 公司簡介
    • AbbVie Inc.
    • Swedish Orphan Biovitrum AB
    • AstraZeneca
    • Johnson & Johnson Services Inc.
    • Sanofi
    • Merck & Co., Inc.
    • Bausch Health Companies Inc.
    • Celltrion Inc.
    • mAbxience
    • Enanta Pharmaceuticals, Inc.
    • Moderna, Inc.
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Novavax, Inc.
    • Roche Holding AG
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2946

REPORT HIGHLIGHT

Respiratory Syncytial Virus Drugs Market size was valued at USD 5,890.20 Million in 2023, expanding at a CAGR of 12.90% from 2024 to 2032.

A frequent virus that affects the respiratory system is called Respiratory Syncytial Virus (RSV), and it usually affects small children, the elderly, and people with weakened immune systems. Several medications and therapies are used to treat RSV infection.

Respiratory Syncytial Virus Drugs Market- Market Dynamics

Growing awareness about RSV infections and diagnosis is expected to propel market demand

The demand for RSV medications and preventive therapy has increased because of increased knowledge of RSV and improvements in diagnostic methods, which have led to more frequent and earlier infection diagnoses. For both small children and the elderly, respiratory illnesses are mostly caused by RSV. The need for efficient treatments and preventive strategies is driven by the high prevalence and recurrent nature of RSV infections. Important motivators include the creation and licensure of novel antiviral medications, monoclonal antibodies, and vaccinations. The market is expected to grow due to efficient treatments being introduced and treatment alternatives being innovated.

The need for efficient RSV medications is driven by the aging population, who are more vulnerable to severe RSV infections. It is anticipated that as the world's population ages, RSV incidence will climb in this group, driving up market demand. Novel therapies and vaccinations are becoming easier to develop because of developments in biotechnology and pharmaceuticals. The availability and efficacy of RSV medications are improved by these technological advancements, which propels market expansion. Regulatory approvals for novel medications and vaccines provide the industry a big boost. Fast-track designations and favorable regulatory conditions for RSV medicines can contribute to the growth of the market.

Respiratory Syncytial Virus Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.90% over the forecast period (2024-2032)

Based on Type segmentation, the approved drugs segment was predicted to show maximum market share in the year 2023, owing to supportive USFDA regulations.

Based on Application segmentation, the clinical diagnostics segment was the leading Application in 2023, due to the high demand for viral drugs in clinical trials & treatment.

Based on End User segmentation, the hospital segment was the leading End User in 2023, owing to high demand for the treatment of respiratory disorders.

On the basis of region, North America was the leading revenue generator in 2023, owing to presence of advanced healthcare infrastructure.

Respiratory Syncytial Virus Drugs Market- Segmentation Analysis:

The Global Respiratory Syncytial Virus Drugs Market is segmented on the basis of Type, Application, End User, and Region.

The market is divided into two categories based on Type: approved drugs and off-label drugs. The approved drugs segment dominates the market. Technological innovation along with supportive FDA regulations is enhancing the segment growth.

The market is divided into three categories based on the Application: clinical diagnostics, laboratories, and others. The offline stores segment dominates the market. The growing prevalence of syncytial viral infections is a compelling demand for market growth.

The market is divided into three categories based on End Users: hospitals, clinics, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. Significant investment in healthcare and advanced infrastructure is accelerating the growth of the market.

Respiratory Syncytial Virus Drugs Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is dominating the global market. The region holds a larger market share because of its substantial R&D expenditures, sophisticated medical infrastructure, and high healthcare spending, North America is one of the biggest markets for RSV medications.

Respiratory Syncytial Virus Drugs Market- Competitive Landscape:

The respiratory syncytial virus drugs market is moderately competitive. Prominent players in the market focus on partnerships among pharmaceutical firms, academic institutions, and healthcare providers might expedite the creation and dissemination of RSV medications, thereby augmenting the market. Some of the major companies include AstraZeneca, Johnson & Johnson, Sanofi, Merck & Co., and newer companies like Moderna. Smaller companies are looking to offer innovative solutions and get USFDA approvals.

Recent Developments:

In February 2024, GSK plc received the USFDA approvals to expand their respiratory syncytial virus vaccination for people over 50.

In May 2023, Pfizer, Inc. introduced a bivalent RSV vaccine with USFDA approval for preventing respiratory tract illness.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RESPIRATORY SYNCYTIAL VIRUS DRUGS MARKET KEY PLAYERS

  • AbbVie Inc.
  • Swedish Orphan Biovitrum AB
  • AstraZeneca
  • Johnson & Johnson Services Inc.
  • Sanofi
  • Merck & Co., Inc.
  • Bausch Health Companies Inc.
  • Celltrion Inc.
  • mAbxience
  • Enanta Pharmaceuticals, Inc.
  • Moderna, Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novavax, Inc.
  • Roche Holding AG
  • Others

GLOBAL RESPIRATORY SYNCYTIAL VIRUS DRUGS MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Approved drugs
  • Off-label drugs

GLOBAL RESPIRATORY SYNCYTIAL VIRUS DRUGS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Clinical diagnostics
  • Laboratories
  • Others

GLOBAL RESPIRATORY SYNCYTIAL VIRUS DRUGS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Clinics
  • Others

GLOBAL RESPIRATORY SYNCYTIAL VIRUS DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Respiratory Syncytial Virus Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Respiratory Syncytial Virus Drugs Market Snippet by Type
    • 2.1.2. Respiratory Syncytial Virus Drugs Market Snippet by Application
    • 2.1.3. Respiratory Syncytial Virus Drugs Market Snippet by End User
    • 2.1.4. Respiratory Syncytial Virus Drugs Market Snippet by Country
    • 2.1.5. Respiratory Syncytial Virus Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Respiratory Syncytial Virus Drugs Key Market Trends

  • 3.1. Respiratory Syncytial Virus Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Respiratory Syncytial Virus Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Respiratory Syncytial Virus Drugs Market Opportunities
  • 3.4. Respiratory Syncytial Virus Drugs Market Future Trends

4. Respiratory Syncytial Virus Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Respiratory Syncytial Virus Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Respiratory Syncytial Virus Drugs Market Landscape

  • 6.1. Respiratory Syncytial Virus Drugs Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Respiratory Syncytial Virus Drugs Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Approved drugs
    • 7.1.3. Off-label drugs

8. Respiratory Syncytial Virus Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Clinical diagnostics
    • 8.1.3. Laboratories
    • 8.1.4. Others

9. Respiratory Syncytial Virus Drugs Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Respiratory Syncytial Virus Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Respiratory Syncytial Virus Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Respiratory Syncytial Virus Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Respiratory Syncytial Virus Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Respiratory Syncytial Virus Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Respiratory Syncytial Virus Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Respiratory Syncytial Virus Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AbbVie Inc.
    • 11.2.2. Swedish Orphan Biovitrum AB
    • 11.2.3. AstraZeneca
    • 11.2.4. Johnson & Johnson Services Inc.
    • 11.2.5. Sanofi
    • 11.2.6. Merck & Co., Inc.
    • 11.2.7. Bausch Health Companies Inc.
    • 11.2.8. Celltrion Inc.
    • 11.2.9. mAbxience
    • 11.2.10. Enanta Pharmaceuticals, Inc.
    • 11.2.11. Moderna, Inc.
    • 11.2.12. Pfizer Inc.
    • 11.2.13. GlaxoSmithKline plc
    • 11.2.14. Novavax, Inc.
    • 11.2.15. Roche Holding AG
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Respiratory Syncytial Virus Drugs Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Respiratory Syncytial Virus Drugs Market, by Type 2019-2032 (USD Million)
  • TABLE Respiratory Syncytial Virus Drugs Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Respiratory Syncytial Virus Drugs Market, by Application 2019-2032 (USD Million)
  • TABLE Respiratory Syncytial Virus Drugs Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Respiratory Syncytial Virus Drugs Market, by End User 2019-2032 (USD Million)
  • TABLE Respiratory Syncytial Virus Drugs Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Respiratory Syncytial Virus Drugs Market, by Region 2019-2032 (USD Million)
  • TABLE North America Respiratory Syncytial Virus Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Respiratory Syncytial Virus Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Respiratory Syncytial Virus Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Respiratory Syncytial Virus Drugs Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Respiratory Syncytial Virus Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Respiratory Syncytial Virus Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Respiratory Syncytial Virus Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Respiratory Syncytial Virus Drugs Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Respiratory Syncytial Virus Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Respiratory Syncytial Virus Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Respiratory Syncytial Virus Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Respiratory Syncytial Virus Drugs Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Respiratory Syncytial Virus Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Respiratory Syncytial Virus Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Respiratory Syncytial Virus Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Respiratory Syncytial Virus Drugs Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Respiratory Syncytial Virus Drugs Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Respiratory Syncytial Virus Drugs Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Respiratory Syncytial Virus Drugs Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Respiratory Syncytial Virus Drugs Market, by End User, 2019-2032 (USD Million)